Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (1), 66-75
- https://doi.org/10.1016/s0149-2918(00)87978-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 1993
- Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelAntimicrobial Agents and Chemotherapy, 1992
- Continuous infusion of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1992
- Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse modelAntimicrobial Agents and Chemotherapy, 1991
- Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection ModelsThe Journal of Infectious Diseases, 1989
- Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic ratsAntimicrobial Agents and Chemotherapy, 1986
- Therapeutic Efficacy of Continuous Versus Intermittent Administration of Ceftazidime in an Experimental Klebsiella pneumoniae Pneumonia in RatsThe Journal of Infectious Diseases, 1985
- Treatment of gram-negative bacillary septicemia with cefoperazoneEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patientsAmerican Journal Of Medicine, 1979